Litcius/Paper detail

1758O Neoadjuvant pembrolizumab in localized/locally advanced solid tumors with mismatch repair deficiency

Kaysia Ludford, Kanwal Pratap Singh Raghav, Michelle Murphy, Nicole D. Fleming, Daniel W. Nelson, M.S. Lee, Brandon G. Smaglo, Yanjie You, Matthew M. Tillman, Carlos Kamiya-Matsuoka, Selvi Thirumurthi, Craig Messick, B. E. Johnson, Eduardo Vilar, José Thomas, Wen‐Chi Foo, W. Qiao, Scott Kopetz, Michael J. Overman

2021Annals of Oncology17 citationsDOI

Topics & Concepts

MedicinePembrolizumabClinical endpointInternal medicineMicrosatellite instabilityOncologyNeuroendocrine tumorsClinical trialPrimary tumorResponse Evaluation Criteria in Solid TumorsPhases of clinical researchCancerSurgeryMetastasisImmunotherapyBiochemistryAlleleGeneMicrosatelliteChemistryGenetic factors in colorectal cancerCancer Genomics and DiagnosticsColorectal and Anal Carcinomas
1758O Neoadjuvant pembrolizumab in localized/locally advanced solid tumors with mismatch repair deficiency | Litcius